Search research articles
Contact Us
Filters
Showing results (191-200 of 235) with videos related to
Page
of 24
Sort By:
NPJ Precision Oncology
|
November 19, 2025
Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrum
Kelsey E Breen, Nikita Mehta, Vignesh Ravichandran, et al.
Lancet (London, England)
|
June 24, 2019
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
William D Tap, Hans Gelderblom, Emanuela Palmerini, et al.
Cancer Discovery
|
June 13, 2018
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 <sup>c259</sup>T Cells in Synovial Sarcoma
Sandra P D'Angelo, Luca Melchiori, Melinda S Merchant, et al.
JAMA Oncology
|
January 24, 2020
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial
Ciara M Kelly, Cristina R Antonescu, Timothy Bowler, et al.
Molecular Cancer Research : MCR
|
March 23, 2021
Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
Emily K Slotkin, Anita S Bowman, Max F Levine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2023
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma
Ciara M Kelly, Li-Xuan Qin, Karissa A Whiting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2024
CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib
Hans Gelderblom, Albiruni A Razak, Matthew H Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2021
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT
William D Tap, Arun S Singh, Stephen Patrick Anthony, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2022
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors
Ping Chi, Li-Xuan Qin, Niedzica Camacho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2016
Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma
Mrinal M Gounder, Alona Zer, William D Tap, et al.
Page
of 24
Search research articles
Search
Showing results (191-200 of 235) with videos related to
Sort By:
Page
of 24
NPJ Precision Oncology
|
November 19, 2025
Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrum
Kelsey E Breen, Nikita Mehta, Vignesh Ravichandran, et al.
Lancet (London, England)
|
June 24, 2019
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
William D Tap, Hans Gelderblom, Emanuela Palmerini, et al.
Cancer Discovery
|
June 13, 2018
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 <sup>c259</sup>T Cells in Synovial Sarcoma
Sandra P D'Angelo, Luca Melchiori, Melinda S Merchant, et al.
JAMA Oncology
|
January 24, 2020
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial
Ciara M Kelly, Cristina R Antonescu, Timothy Bowler, et al.
Molecular Cancer Research : MCR
|
March 23, 2021
Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
Emily K Slotkin, Anita S Bowman, Max F Levine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2023
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma
Ciara M Kelly, Li-Xuan Qin, Karissa A Whiting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2024
CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib
Hans Gelderblom, Albiruni A Razak, Matthew H Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2021
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT
William D Tap, Arun S Singh, Stephen Patrick Anthony, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2022
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors
Ping Chi, Li-Xuan Qin, Niedzica Camacho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2016
Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma
Mrinal M Gounder, Alona Zer, William D Tap, et al.
Page
of 24